Qube Research & Technologies (QRT)’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7M Buy
+287,222
New +$12.3M 0.01% 1345
2023
Q2
– Sell
-46,213
Closed -$427K – 3046
2023
Q1
$427K Buy
46,213
+29,320
+174% +$270K ﹤0.01% 1611
2022
Q4
$150K Buy
16,893
+3,604
+27% +$34.1K ﹤0.01% 1897
2022
Q3
$111K Sell
13,289
-1,654
-11% -$13.7K ﹤0.01% 1946
2022
Q2
$122K Buy
+14,943
New +$103K ﹤0.01% 1870

Other funds holding URGN

Qube Research & Technologies (QRT)'s URGN Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in UroGen Pharma (URGN) in Q3 2026: 287,222 shares worth $11.7M. The stake represents 0.01% of the portfolio and ranks #1345 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in URGN as recently as Q1 2023.

Qube Research & Technologies (QRT) first reported a position in URGN in Q2 2022 and has held it in 5 quarters since. 207 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • Qube Research & Technologies (QRT) held 287,222 shares of UroGen Pharma worth $11.7M as of Q3 2026.
  • UroGen Pharma was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • UroGen Pharma made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1345 holding.
  • Qube Research & Technologies (QRT) first reported a position in UroGen Pharma in Q2 2022 and has held it in 5 quarters since.
  • 207 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.